why choose us

First received: December 22, 2024

Clinical Trial: Clinical Trial Evaluate the Cough-relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children in Outpatient-treated Pharyngitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cough Severity

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label, Single-Center, Controlled Clinical Trial to Evaluate the Cough-Relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children With Outpatient-T

Brief Summary: This is a randomized, open-label, single-center clinical trial evaluating the efficacy and safety of Azka Nasal and Throat for Children compared to the control drug Prospan Cough Syrup in children aged 4-6 years diagnosed with acute nasopharyngitis.Participants will be randomly assigned in a 1:1 ratio to receive either Azka Nasal and Throat or Prospan Cough Syrup for 7 days.The study aims to assess improvements in cough and phlegm conditions, as well as monitor adverse events associated with the interventions.Data…

Read more